REQUEST A DEMO
Total
USD $0.00
Search more companies

Precision Biosensor Inc. (South Korea)

Main Activities: Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: Precision Biosensor Inc. Profile Updated: February 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Precision Biosensor, Inc offers diagnostic solutions using TRF fluorescence technology with an immune diagnosis platform and chemical analysis. Their products include cardiovascular cartridges for diagnosing heart disease and an animal diagnosis platform. Precision Biosensor collaborates with global companies and research institutes to develop and commercialize diagnostic items and provides POCT commercialization solutions.

Headquarters
306, Techno 2-Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Precision Biosensor Inc. report to view the information.

Website: http://precision-bio.com

Basic Information
Total Employees:
Purchase the Precision Biosensor Inc. report to view the information.
Outstanding Shares:
Purchase the Precision Biosensor Inc. report to view the information.
Registered Capital:
Purchase the Precision Biosensor Inc. report to view the information.
Financial Auditors:
Purchase the Precision Biosensor Inc. report to view the information.
Incorporation Date:
September 28, 2009
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
Nano-Ditech Co., Ltd
Company Performance
Financial values in the chart are available after Precision Biosensor Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-6.16%
Total operating revenue
-6.67%
Operating Profit/Loss (EBIT)
-15.93%
EBITDA
-20.88%
Net Profit/Loss for the Period
-62.69%
Total Assets
-16.71%
Total Equity
-19.76%
Operating Profit Margin (ROS)
-5%
Net Profit Margin
-16.16%
Return on Equity (ROE)
-14.41%
Debt/Equity
5.35%
Quick Ratio
-0.31%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?